Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Clinical trial NCT06171750 · RECRUITING

Trial details

NCT number: NCT06171750
Sponsor: Ankyra Therapeutics, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cutaneous Tumor Subcutaneous Tumor Malignant Solid Tumor Solid Tumor Metastatic Solid Tumor Metastasis to Soft Tissue Non Small Cell Lung Cancer Cutaneous Squamous Cell Carcinoma

Start date: 2024-01-19
Primary completion: 2027-04-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.